Business
Currency:USD
2025/Q2
Stock NameRevenueRatio
Pharmacology services12.5M92.65%
Other Translational Oncology Solutions (TOS) revenue991K7.35%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States50.16M100.00%